Home » Newsletters » BioWorld Science

BioWorld Science

July 14, 2022

View Archived Issues

FVIII-QQ gene transfer therapy shows advantage for treating hemophilia A

Novel genetic polymorphism associated with macroangiopathy risk

UCB SA patents DRD1 PAMs

Merck & Co. discloses new DNA polymerase inhibitors

Pfizer synthesizes IL-2 production inhibitors

Janssen Pharmaceutica identifies new Mcl-1 inhibitors

GLS1 inhibitor with antitumor activity in HCT116 xenograft model

Heptares Therapeutics divulges new histamine H4 receptor antagonists

Inflammation, coagulation and endothelial activation markers linked to HIV-associated TTP

A new series of broad-spectrum bacterial type II topoisomerase inhibitors: synthesis and evaluation

New salicylic acid derivatives act as double GO/LACH inhibitors to decrease oxalate production

SNP rs11549465 in HIF1A gene predicts glucocorticoid sensitivity in patients with ITP

FDA awards orphan drug designation to AVR-RD-05 for Hunter's syndrome

CytomX restructures and outlines plans for preclinical pipeline

KDM4B enzyme inhibitor tested for aggressive rhabdomyosarcoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...